MDXH Competitors & Alternatives
Compare MDxHealth SA with similar stocks in the same industry
Diagnostics & Research
MDXH
Main Stock$0.21
Tradestie Score
41
Market Cap
$231.40M
Revenue Growth
0.0%
Analyst Upside
+287.9%
Top Competitors
40 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CDNA
CareDx, Inc.
|
$70.74
|
$798.40M | 33.3 | 30 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$20.13
|
$719.31M | - | 63 | Compare |
|
MYGN
Myriad Genetics Inc
|
$5.57
|
$719.23M | - | 39 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$34.37
|
$667.77M | - | 57 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$15.90
|
$612.76M | - | 57 | Compare |
|
NYXH
Nyxoah SA Ordinary Shares
|
$0.90
|
$185.47M | - | 37 | Compare |
|
SERA
Sera Prognostics, Inc. Class A Common Stock
|
$2.03
|
$112.28M | - | 49 | Compare |
|
LUCD
Lucid Diagnostics Inc. Common Stock
|
$0.33
|
$103.93M | - | 39 | Compare |
|
BDSX
Biodesix, Inc. Common Stock
|
$23.93
|
$61.36M | - | 66 | Compare |
|
DRMA
Dermata Therapeutics, Inc. Common Stock
|
$0.80
|
$3.50M | - | 51 | Compare |
More MDXH Analysis
Data updated: Oct 21, 2026 | Industry: Diagnostics & Research (SIC 8071)
40 stocks in this industry